Back to results
RecruitingPhase 2

Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction

NCT04680442

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Hospital de Clínicas de Porto Alegre

Porto Alegre, Rio Grande do Sul, Brazil

+7 additional locations

Contact

Maha Mushtaha, BSc

9052973479maha.mushtaha@phri.ca
View on ClinicalTrials.gov
Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction — TrialFind